Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Investigation of serum β-defensin-1 level in calves with coccidiosis

Akın Koçhan.




Abstract

Objective: Coccidiosis is a protozoan infection that can result in hemorrhagic diarrhea, depres¬sion, weakness, weight loss, and even mortality in young animals. β-defensin-1 is an antimicro¬bial peptide produced largely by epithelial cells in the skin and mucosa. It possesses antifungal, antibacterial, antiparasitic, and antiviral properties. The goal of this study was to evaluate how β-defensin-1 levels changed in coccidiosis-infected calves.
Materials and Methods: The sample included 10 coccidiosis-positive calves and 7 healthy calves, for a total of 17 calves of diverse breeds and older than 15 days. To assess the level of β-defen¬sin-1, blood samples were obtained from the vena jugularis of the animals. The concentrations of β-defensin-1 in the serum were measured using a commercial ELISA kit.
Results: Although the serum β-defensin-1 level decreased in infected animals, the drop was not statistically significant when compared to the control group.
Conclusion: According to the study’s findings, there was no significant change in the serum β-de¬fensin-1 level in coccidiosis-infected calves. We believe that it will be advantageous to conduct additional studies with a larger sample size in order to acquire more precise results.

Key words: β-defensin-1; calf; coccidiosis; level; serum






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.